Fortress Biotech (FBIO) Stock: Buy, Sell, or Hold?
FBIO - Fortress Biotech, Inc.
$1.93
-0.06 (-3.02%)
▼
5d:
+3.21%
30d:
-15.35%
90d:
-40.98%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 13, 2026
19d
Get Alerted When FBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: FBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: FBIO is currently trading at $1.93, which is considered oversold relative to its 30-day fair value range of $1.94 to $2.35. From a valuation perspective, the stock is trading at a discount (Forward PE: -1.9) compared to its historical average (136.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, FBIO is in a strong downtrend. Immediate support is located at $1.83, while resistance sits at $2.13. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.00 (+159.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FBIO is in a strong downtrend. Immediate support is located at $1.83, while resistance sits at $2.13. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.00 (+159.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.94 -
$2.35
Company Quality Score
64/100
(BUY)
Options IV Signal
24th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
83.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 24th percentile)
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 159.1% below Wall St target ($5.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- NEUTRAL: Bottoming setup forming (48/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$1.94 -
$2.35
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.20
(10.3%)
Support & Resistance Levels
Support Level
$1.83
Resistance Level
$2.13
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.93
Wall Street Target
$5.00
(+159.1%)
Revenue Growth (YoY)
14.0%
Profit Margin
163.3%
PE vs Historical
-1.9 vs 136.2
CHEAP
Share & Embed Analysis
Last updated: October 24, 2026 1:26 AM ET
Data refreshes hourly during market hours. Next update: 2:26 AM
Data refreshes hourly during market hours. Next update: 2:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 53 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 64 BUY |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 75 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 59 HOLD |
